All Type of News
Health ministry to improve domestic R&D environmentThe Ministry of Health and Welfare unveiled the plan on July 26 to encourage the research and development (R&D) activities of domestic pharmaceutical firms after screening their...
|
SK Chemicals erectile dysfunction drug receives marketing Approval in KoreaSK Chemicals announced that it has recently received marketing approval from the Korean Food and Drug Administration for mirodenafil, a new phosphodiesterase type 5 (PDE5) inhib...
|
Dongwha and Samsung on big marketing wars on Whalmyungsoo.
A big market combating bout seems to be struck between Dongwha and Samsung with "Gas whalmyungsoo" and "Gas-myungsoo" through the TV CF.
Two companies tried to refresh their old image of Whalmyungsoo by displaying ...
GSK to launch once every 3 month injectable drug for osteoporosis.
GSK Korea announced to launch Bonviva (ibandronate), an anti-osteoporosis therapy for menopause women, once every 3 month injectable administration via intra-vein.
Bonviva is a class of the biphosphonate drugs with...
Novartis's Tasigna receives first approval in Switzerland
Novartis's cancer treatment Tasigna has received approval in Switzerland, its first certification worldwide.
Switzerland is the first country to approve the drug, which offers a cancer therapy for patients with a f...
KFDA orders sales suspension for Novartis' famvir cream
The government said on July 25 that it banned the sales of Novartis Korea's Famvir (famciclovir) and Dongyang Pharm's cimetiidne and famotidine for six months on grounds of their failure to submit related documents fo...
Generic drug prices to fall by 20 percent on average
When a generic drug gets listed for insurance coverage, the price of the corresponding drug will be determined by 80 to 100 percent versus the original drug, the Ministry of Health and Welfare said on July 24.
Und...
Many anti-obesity drugs on hot market competition.
A serial market launching of local generic drugs for anti-obesity therapy such as Slimmer and NVU raised a hot market competition, and the market success of which seems to be largely depended on its ex-manufacturers p...
Foreign drug makers asked to diversify drug distribution sources
The Ministry of Health and Welfare and the Korean Pharmaceutical Association has repeatedly asked multinational drug manufactures, who are outsourcing their drugs to Zuellig Pharma Korea, to diversify their outlets, a...
Hanmi to sell Slimmer to Australia.
Hanmi has agreed to supply Slimmer to Australia, which will be a good stepping stone for an entry of the European markets.
Hanmi announced on July 24 that the company made a distribution agreement with iNova in Aus...
